Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Ovarian Cancer Individualized Scoring System (OCISS) for Prediction of Ovarian Cancer Prognosis

NCT05496517 is registered in ClinicalTrials.gov with Assiut University as lead sponsor.

NCT NCT05496517
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05496517 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Ovarian Cancer Individualized Scoring System (OCISS) for Prediction of Ovarian Cancer Prognosis
Lead sponsor
Assiut University
Phase
Observational
Overall status
Unknown status
Start date
November 11, 2022
Completion date
November 22, 2023
Enrollment
1,000 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

ovarian cancer